A phase II, open label, randomized controlled trial of nivolumab plus ipilimumab with stereotactic radiotherapy versus ipilimumab plus nivolumab alone in patients with melanoma brain metastases (ABC-X Trial) Meeting Abstract
| Authors: | Gonzalez, M.; Hong, A. M.; Carlino, M. S.; Atkinson, V.; Wang, W.; Lo, S.; Brown, M. P.; Foote, M. C.; Pinkham, M. B.; Le, H.; Roos, D. E.; Osorio, M.; Haghighi, N.; Kok, D.; Postow, M. A.; McArthur, G. A.; Menzies, A. M.; Long, G. V. |
| Abstract Title: | A phase II, open label, randomized controlled trial of nivolumab plus ipilimumab with stereotactic radiotherapy versus ipilimumab plus nivolumab alone in patients with melanoma brain metastases (ABC-X Trial) |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 533s |
| Language: | English |
| ACCESSION: | WOS:000487345803479 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.TPS9600 |
| PROVIDER: | Clarivate Analytics Web of Science |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS9600 -- Source: Wos |
